Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-12 4:17 pm Sale |
2021-08-10 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 2,212,571 5.600% |
-254,721 (-10.32%) |
Filing History |
| 2021-03-19 6:06 pm Sale |
2021-03-17 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 2,467,292 6.800% |
-298,425 (-10.79%) |
Filing History |
| 2021-02-16 12:07 pm Purchase |
2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital, LLC | 3,092,218 8.700% |
450,000 (+17.03%) |
Filing History |
| 2021-02-12 6:24 pm Purchase |
2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
The Column Group II, LP | 4,768,181 13.100% |
4,768,181 (New Position) |
Filing History |
| 2021-02-08 10:29 am Purchase |
2021-02-05 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR LLC | 5,452,347 14.999% |
2,215,014 (+68.42%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
1,878,908 5.300% |
1,878,908 (New Position) |
Filing History |
| 2020-11-18 2:42 pm Unchanged |
2020-11-17 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 2,765,717 7.800% |
0 (Unchanged) |
Filing History |
| 2020-11-05 08:53 am Sale |
2020-11-04 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Topspin Fund L.P. | 1,100,446 3.670% |
-2,212,178 (-66.78%) |
Filing History |